This is the 16th episode of 16 Minutes, our news show where we cover the top headlines, the a16z Podcast way: what’s real / what’s hype; why they matter from our vantage point in tech.
This week, we cover the following news (in conversation with Sonal Chokshi):
- NYSE & SEC back and forth over direct listings — The NYSE recently proposed allowing companies to raise capital during direct listings (currently, they’re different than IPOs in that there is no offering); the SEC rejected it; and they just filed a new proposal… but beyond this news and these artifacts, what’s the bigger picture when it comes to other structural factors involved here? — with Scott Kupor.
- vaping apps & Apple; FDA & CBD — two recent moves: Apple banning 181 vaping apps from its app store, FDA issuing warning letters against 15 companies with products that have CBD in them; what’s our quick take on the blurring lines between these two seemingly different bits of news? — with Vijay Pande.
Relevant/ related links:
- IPOs, direct listings, more:
More From These Contributors
-
Longevity as a Health Asset with Tom Hale
Tom Hale, Vijay Pande, Daisy Wolf, Kris Tatiossian, and Olivia Webb
-
The Power of Drug Discovery with Philip Tagari
Vijay Pande, Philip Tagari, Kris Tatiossian, and Olivia Webb
-
AI-Enabled Continuity of Care with Ed and Todd Park
Vijay Pande, Ed Park, Todd Park, Steph Smith, Kris Tatiossian, and Olivia Webb
-
Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Vijay Pande, Julie Yoo, Kris Tatiossian, and Olivia Webb
-
Biotech Revolution with Software Engineering Daily
Sean Falconer, Vijay Pande, Kris Tatiossian, and Olivia Webb